Standard BioTools Inc.LABNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank21
3Y CAGR-11.1%
5Y CAGR-4.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-11.1%/yr
vs +4.4%/yr prior
5Y CAGR
-4.8%/yr
Recent deceleration
Acceleration
-15.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $42.79M | -52.5% |
| 2024 | $90.17M | +61.3% |
| 2023 | $55.89M | -8.2% |
| 2022 | $60.90M | -0.5% |
| 2021 | $61.21M | +11.7% |
| 2020 | $54.82M | +3.5% |
| 2019 | $52.96M | +3.2% |
| 2018 | $51.31M | +2.7% |
| 2017 | $49.95M | +8.6% |
| 2016 | $46.01M | - |